Mar 30, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry
its use in women will be somewhat minimal,” Butler said.
Mar 30, 2013 ... New Climate-Friendlier Coolant Has a Catch: It's Flammable ... F.D.A. Approves a
New Diabetes Drug From J.&J. ... The drug, Invokana, will be sold by Johnson &
Johnson and treats patients with type 2 diabetes in a new way, ...
On its approval, analysts expected peak sales of around $650 million for
Invokana, but competitors ... a diabetes drug, and the heads of its Janssen unit
hope Invokana's success will ... J&J wins first FDA approval for new class of
Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ...
As the first company to win FDA approval, Johnson & Johnson has a leg up on
industry rivals developing their own ... More details on the studies will be
presented at the American Diabetes Association annual meeting in June.
May 20, 2015 ... J&J has a lofty goal of churning out new blockbusters from its ... new drugs and
40 line extensions for regulatory approval by 2019. ... Many analysts predict the
product will be among the company's ... that it is exploring safety concerns
regarding diabetes drugs that are in a class known as “SGL2 inhibitors.
Mar 8, 2013 ... Johnson & Johnson has been battling with patent cliffs like many in the industry,
but ... After this, the European Medicines Agency approval should not be far away
. The type 2 diabetes drug had earlier shown strong efficacy in reducing ... Merck,
the clear market leader with its blockbuster drugs Januvia and ...
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.
Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the
first in its class to be approved in the United States. The U.S. ...
Sep 28, 2016 ... The U.S. Food and Drug Administration, in its approval of the device, the ...
Patients will still need to instruct the device to deliver extra insulin for meals ...
Johnson & Johnson , Tandem Diabetes Care Inc and Insulet Corp, are ...
Invokana (canagliflozin) – manufactured by Janssen, a division of Johnson &
Johnson ... Diabetes is a medical condition in which the body does not process
sugar correctly. ... Farxiga was the first SGLT2 drug the FDA considered for
approval. ... Public Citizen has all three medications on its “Do Not Use” list on its